lidocaine and galactose

lidocaine has been researched along with galactose in 20 studies

Research

Studies (20)

TimeframeStudies, this research(%)All Research%
pre-19901 (5.00)18.7374
1990's9 (45.00)18.2507
2000's7 (35.00)29.6817
2010's2 (10.00)24.3611
2020's1 (5.00)2.80

Authors

AuthorsStudies
Becker, H; Ebener, T; Groteguth, R; Niederau, C; Stremmel, W; Strohmeyer, G; Wojdat, R; Zoedler, M1
Beyrau, R; Burdelski, M; Gubernatis, G; Lamesch, P; Oellerich, M; Pichlmayr, R; Ringe, B1
Encke, J; Gerlach, JC; Hole, O; Müller, C; Neuhaus, P; Ryan, CJ1
Luo, H; Meyer-Wyss, B; Renner, E; Scholer, A1
Deng, JF; Huang, YS; Lee, SD; Lin, YF; Lo, KJ; Lu, RH; Wang, YJ; Wu, JC1
Becker, H; Ebener, C; Roeher, HD; Zoedler, T1
Bovée, WM; Chamuleau, RA; Flendrig, LM; Jörning, GG; Karlsen, OT; la Soe, JW; Ladiges, NC; Steenbeek, A; te Velde, AA1
Aratani, A; Asahara, T; Dohi, K; Hino, H; Katayama, S; Kohashi, T; Sato, H; Tateno, C; Yamasaki, C; Yoshizato, K1
Ikai, I; Iwata, H; Kanazawa, A; Katura, N; Nishitai, R; Okabe, H; Satoh, S; Takeyama, O; Terajima, H; Uesugi, T; Yagi, T; Yamaoka, Y; Yoneyama, T1
Baker, AB; Gao, L; Ramzan, I1
Borro, P; Botta, F; Chiarbonello, B; Fasoli, A; Fumagalli, A; Giannini, E; Malfatti, F; Polegato, S; Romagnoli, P; Savarino, V; Testa, E; Testa, R1
Behrmann, C; Fleig, WE; Kleber, G; Meiss, F; Steudel, N; Sziegoleit, U; Zipprich, A1
Park, YG; Ryu, HW; Son, YS1
Beste, M; Broelsch, CE; Farahani, MS; Gerken, G; Jochum, C; Malago, M; Nadalin, S; Penndorf, V; Testa, G1
Addario, L; Ascione, A; De Luca, M; Di Costanzo, GG; Galeota Lanza, A; Giannelli, E; Lampasi, F; Macr, M; Picciotto, FP; Scaglione, G; Tartaglione, MT; Tritto, G; Utech, W1
Beste, M; Gerken, G; Kahraman, A; Miller, M; Ross, B1
Borneman, R; Brayfield, C; Gerlach, JC; Müller, C; Puhl, G; Schmelzer, E; Zeilinger, K1
Huang, L; Lin, X; Lin, Y; Zheng, X1
Hicks, FF; Hicks, JS; Turner, MD; Warren, RB1
Acosta, EJ; Chu, J; Nguyen, N; Wen, XY; Yip, A; Yuan, JS1

Reviews

2 review(s) available for lidocaine and galactose

ArticleYear
Potential use of pharmacological markers to quantitatively assess liver function during liver transplantation surgery.
    Anaesthesia and intensive care, 2000, Volume: 28, Issue:4

    Topics: Adult; Antipyrine; Biomarkers; Breath Tests; Caffeine; Coloring Agents; Galactose; Humans; Indocyanine Green; Lidocaine; Liver; Liver Function Tests; Liver Transplantation; Postoperative Period; Reference Values

2000
Perifusion model for detoxification of drugs in a bioartificial liver.
    The International journal of artificial organs, 2003, Volume: 26, Issue:5

    Topics: Anti-Arrhythmia Agents; Galactose; Humans; Inactivation, Metabolic; Lidocaine; Liver; Liver, Artificial; Metabolic Clearance Rate; Models, Biological

2003

Trials

1 trial(s) available for lidocaine and galactose

ArticleYear
Measuring lidocaine metabolite--monoethylglycinexylidide as a quantitative index of hepatic function in adults with chronic hepatitis and cirrhosis.
    Journal of hepatology, 1993, Volume: 19, Issue:1

    Topics: Adult; Chronic Disease; Female; Follow-Up Studies; Galactose; Hepatitis; Humans; Indocyanine Green; Lidocaine; Liver Cirrhosis; Liver Function Tests; Male; Middle Aged; Prognosis; Prospective Studies; Prothrombin Time; Serum Albumin

1993

Other Studies

17 other study(ies) available for lidocaine and galactose

ArticleYear
[Liver function tests in a clinical comparison].
    Zeitschrift fur Gastroenterologie, 1992, Volume: 30, Issue:11

    Topics: Cholinesterases; Factor V; Factor VII; Galactose; Hepatic Encephalopathy; Humans; Indocyanine Green; Lidocaine; Liver Cirrhosis; Liver Function Tests; Metabolic Clearance Rate; Prealbumin; Prothrombin Time; Reference Values; Serum Albumin

1992
Assessment of liver function in the early postoperative period after liver transplantation with ICG, MEGX, and GAL tests.
    Transplantation proceedings, 1990, Volume: 22, Issue:4

    Topics: Galactose; Humans; Indocyanine Green; Lidocaine; Liver Function Tests; Liver Transplantation; Postoperative Period

1990
Bioreactor for a larger scale hepatocyte in vitro perfusion.
    Transplantation, 1994, Nov-15, Volume: 58, Issue:9

    Topics: Animals; Biotechnology; Cells, Cultured; Endothelium; Galactose; Lidocaine; Liver; Male; Midazolam; Perfusion; Swine

1994
Assessment of lidocaine metabolite formation in comparison with other quantitative liver function tests.
    Journal of hepatology, 1993, Volume: 19, Issue:1

    Topics: Adolescent; Adult; Aminopyrine; Breath Tests; Child; Galactose; Humans; Lidocaine; Liver Diseases; Liver Function Tests

1993
Evaluation of liver function tests to predict operative risk in liver surgery.
    HPB surgery : a world journal of hepatic, pancreatic and biliary surgery, 1995, Volume: 9, Issue:1

    Topics: Galactose; Humans; Indocyanine Green; Lidocaine; Liver Diseases; Liver Failure; Liver Function Tests; Postoperative Complications; Predictive Value of Tests; Risk Factors

1995
In vitro evaluation of a novel bioreactor based on an integral oxygenator and a spirally wound nonwoven polyester matrix for hepatocyte culture as small aggregates.
    Journal of hepatology, 1997, Volume: 26, Issue:6

    Topics: Amino Acids; Animals; Bioreactors; Biotransformation; Cell Culture Techniques; Equipment Design; Galactose; Lidocaine; Liver; Liver Function Tests; Liver, Artificial; Magnetic Resonance Imaging; Microscopy, Electron; Microscopy, Electron, Scanning; Polyesters; Swine; Time Factors; Urea

1997
A long-term culture of human hepatocytes which show a high growth potential and express their differentiated phenotypes.
    Biochemical and biophysical research communications, 1999, Mar-05, Volume: 256, Issue:1

    Topics: 3T3 Cells; Adult; Aged; Albumins; Animals; Ascorbic Acid; Biomarkers; Blood Proteins; Cell Culture Techniques; Cell Differentiation; Cell Division; Cell Size; Cell Survival; Cells, Cultured; Culture Media, Conditioned; Dimethyl Sulfoxide; DNA; Epidermal Growth Factor; Female; Galactose; Humans; Lidocaine; Liver; Male; Mice; Middle Aged; Niacinamide; Time Factors

1999
Evaluation of ammonia and lidocaine clearance, and galactose elimination capacity of xenoperfused pig livers using a pharmacokinetic analysis.
    Transplantation, 1999, Jul-27, Volume: 68, Issue:2

    Topics: Ammonia; Animals; Bile; Complement Membrane Attack Complex; Extracorporeal Circulation; Galactose; Glutathione Transferase; Hemodynamics; Humans; Immunohistochemistry; Lidocaine; Liver; Liver Transplantation; Transplantation, Heterologous

1999
Impairment of cytochrome P-450-dependent liver activity in cirrhotic patients with Helicobacter pylori infection.
    Alimentary pharmacology & therapeutics, 2001, Volume: 15, Issue:12

    Topics: Aged; Breath Tests; Carbon Radioisotopes; Cytochrome P-450 Enzyme System; Female; Galactose; Helicobacter Infections; Helicobacter pylori; Humans; Immunoglobulin G; Lidocaine; Liver; Liver Cirrhosis; Male; Middle Aged; Retrospective Studies; Tumor Necrosis Factor-alpha

2001
Functional significance of hepatic arterial flow reserve in patients with cirrhosis.
    Hepatology (Baltimore, Md.), 2003, Volume: 37, Issue:2

    Topics: Adenosine; Adult; Blood Flow Velocity; Blood Volume; Coloring Agents; Female; Galactose; Hepatic Artery; Humans; Indocyanine Green; Lidocaine; Liver Cirrhosis; Male; Middle Aged; Pulse; Regional Blood Flow; Severity of Illness Index; Vasodilation

2003
Quantitative liver function tests in donors and recipients of living donor liver transplantation.
    Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 2006, Volume: 12, Issue:4

    Topics: Adult; Female; Galactose; Half-Life; Humans; Indocyanine Green; Lidocaine; Liver Diseases; Liver Function Tests; Liver Transplantation; Living Donors; Male; Middle Aged; Treatment Failure; Treatment Outcome

2006
Prognostic value of quantitative liver function tests in viral cirrhosis: a prospective study.
    European journal of gastroenterology & hepatology, 2006, Volume: 18, Issue:7

    Topics: Adult; Disease Progression; Epidemiologic Methods; Female; Galactose; Hepatitis, Viral, Human; Humans; Lidocaine; Liver Cirrhosis; Liver Function Tests; Liver Transplantation; Male; Middle Aged; Prognosis; Severity of Illness Index

2006
Evaluation of quantitative liver function tests in HIV-positive patients under anti-retroviral therapy.
    European journal of medical research, 2009, Sep-01, Volume: 14, Issue:9

    Topics: Adult; Antiviral Agents; Female; Galactose; Half-Life; Hepatitis B; Hepatitis C; HIV Infections; Humans; Lidocaine; Liver; Liver Diseases; Liver Function Tests; Male; Metabolic Clearance Rate; Middle Aged; Prognosis; Reproducibility of Results

2009
Lidocaine/monoethylglycinexylidide test, galactose elimination test, and sorbitol elimination test for metabolic assessment of liver cell bioreactors.
    Artificial organs, 2010, Volume: 34, Issue:6

    Topics: Animals; Bioreactors; Cell Culture Techniques; Cells, Cultured; Galactose; Hepatocytes; Humans; Lidocaine; Liver; Liver Function Tests; Liver, Artificial; Sorbitol; Swine

2010
Effect of lidocaine on cognitively impaired rats: Anti-inflammatory and antioxidant mechanisms in combination with CRMP2 antiphosphorylation.
    Immunity, inflammation and disease, 2023, Volume: 11, Issue:10

    Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Galactose; Lidocaine; Rats; Superoxide Dismutase

2023
The use of metabolic inhibitors in hypothermic kidney storage.
    The Journal of surgical research, 1969, Volume: 9, Issue:12

    Topics: Animals; Antimetabolites; Chlorpromazine; Cortisone; Dogs; Erythritol; Female; Hexoses; Kidney; Lidocaine; Malonates; Penicillins; Refrigeration; Time Factors; Tissue Banks; Tissue Preservation; Vasodilator Agents

1969
Effect of surfactant concentration on transdermal lidocaine delivery with linker microemulsions.
    International journal of pharmaceutics, 2010, Jun-15, Volume: 392, Issue:1-2

    Topics: Administration, Cutaneous; Anesthetics, Local; Animals; Caprylates; Drug Carriers; Emulsions; Hexoses; In Vitro Techniques; Lecithins; Lidocaine; Myristates; Particle Size; Phase Transition; Skin; Skin Absorption; Surface-Active Agents; Swine

2010